Latest Disclosure Policy News

Power Minerals Limited has affirmed that a requested briefing to the Australian Ambassador to the US is market-sensitive information, promptly disclosed in compliance with ASX rules.

Netlinkz Limited has attributed the late filing of a key director disclosure to an administrative error, while affirming its existing compliance frameworks remain robust.

VHM Limited has clarified that a non-binding US$200 million letter of interest from the US Export-Import Bank for its Goschen project is not material to its share price, confirming full compliance with ASX disclosure rules despite recent market speculation.

Nordic Resources Ltd attributes its recent share price and volume spike to a successful investor roadshow and capital raising tied to its new Finland gold projects, while confirming full ASX compliance.

Discovery Alaska Limited has detailed its exploration expenditures and strategic pivot from Alaskan projects to new US acquisitions, affirming its financial health and operational sufficiency to maintain its ASX listing.

Mount Burgess Mining (MTB) has responded to an ASX price query, confirming no undisclosed material information beyond previously announced gold project acquisitions and debt conversion plans ahead of its upcoming EGM.

Hastings Technology Metals has responded to an ASX price query, denying any undisclosed information behind its recent share price and volume spike, citing recent joint venture and asset sale announcements as likely drivers.

Delorean Corporation has clarified the timing and rationale behind its delayed disclosure of a $3.3 million profit reduction linked to grid connection delays on its Yarra Valley Water project.

Felix Gold Limited has been found in breach of ASX continuous disclosure rules after delaying the announcement of a U.S. federal site visit to its Alaska antimony project, prompting an internal review of its disclosure policies.

DigitalX Limited has responded to ASX queries, affirming the legality of its cryptocurrency treasury strategy and outlining plans to expand Bitcoin holdings significantly by 2027 to support its digital asset business.

OncoSil Medical has affirmed the materiality of the PANCOSIL Phase 1-2 trial results and detailed its compliance with ASX disclosure rules following the data presentation at CIRSE 2025.

Aguia Resources has responded to an ASX price query following a dramatic surge in its share price, confirming no new material exploration results have been received or withheld. The company asserts full compliance with continuous disclosure obligations despite market speculation.